How much revenue did Novan generate this year?
Novan has achieved a revenue of 106.42 M USD this year.
Novan Revenue 2025
Novan Revenue
106.42 M USD
Ticker
NOVN
ISIN
US66988N1063
WKN
A2AR9U
In 2025, Novan's sales reached 106.42 M USD, a 40.99% difference from the 75.48 M USD sales recorded in the previous year.
The Novan Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2028e | 252.17 | 6,47 |
| 2027e | 222.35 | 7,33 |
| 2026e | 170.11 | 9,58 |
| 2025e | 106.42 | 15,32 |
| 2024e | 75.48 | 21,60 |
| 2023e | 23.45 | 69,52 |
| 2022 | 23.68 | 68,84 |
| 2021 | 2.96 | 551,15 |
| 2020 | 4.92 | 331,36 |
| 2019 | 4.9 | 332,71 |
| 2018 | 5.99 | 272,17 |
| 2017 | 2.14 | 761,82 |
| 2016 | - | - |
| 2015 | - | - |
| 2014 | 0.11 | 14820,91 |
| 2013 | 2.71 | 601,59 |
Novan Revenue, EBIT, Net Income US66988N1063 · A2AR9U
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Novan, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Novan from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Novan’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Novan. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Novan’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Novan’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Novan’s growth potential.
Novan Revenue, EBIT and net profit per share
| Date | Novan Revenue | Novan EBIT | Novan Net Income |
|---|---|---|---|
| 2028e | 252.17 M undefined | 0 undefined | 37.5 M undefined |
| 2027e | 222.35 M undefined | 97.83 M undefined | 30.13 M undefined |
| 2026e | 170.11 M undefined | 58.44 M undefined | 19.73 M undefined |
| 2025e | 106.42 M undefined | 11.26 M undefined | 5.42 M undefined |
| 2024e | 75.48 M undefined | -9.35 M undefined | 3.47 M undefined |
| 2023e | 23.45 M undefined | -39.23 M undefined | -7.59 M undefined |
| 2022 | 23.68 M undefined | -29.25 M undefined | -31.31 M undefined |
| 2021 | 2.96 M undefined | -29.8 M undefined | -29.69 M undefined |
| 2020 | 4.92 M undefined | -26.17 M undefined | -29.29 M undefined |
| 2019 | 4.9 M undefined | -30.69 M undefined | -30.64 M undefined |
| 2018 | 5.99 M undefined | -28.56 M undefined | -12.67 M undefined |
| 2017 | 2.14 M undefined | -36.19 M undefined | -37.13 M undefined |
| 2016 | 0 undefined | -59.83 M undefined | -59.7 M undefined |
| 2015 | 0 undefined | -25.83 M undefined | -28.06 M undefined |
| 2014 | 110,000 undefined | -11.83 M undefined | -11.39 M undefined |
| 2013 | 2.71 M undefined | -6.37 M undefined | -6.18 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2013 | 2.71 M USD | -6.37 M USD | -6.18 M USD |
| 2014 | 110,000 USD | -11.83 M USD | -11.39 M USD |
| 2015 | 0 USD | -25.83 M USD | -28.06 M USD |
| 2016 | 0 USD | -59.83 M USD | -59.7 M USD |
| 2017 | 2.14 M USD | -36.19 M USD | -37.13 M USD |
| 2018 | 5.99 M USD | -28.56 M USD | -12.67 M USD |
| 2019 | 4.9 M USD | -30.69 M USD | -30.64 M USD |
| 2020 | 4.92 M USD | -26.17 M USD | -29.29 M USD |
| 2021 | 2.96 M USD | -29.8 M USD | -29.69 M USD |
| 2022 | 23.68 M USD | -29.25 M USD | -31.31 M USD |
| 2023e | 23.45 M USD | -39.23 M USD | -7.59 M USD |
| 2024e | 75.48 M USD | -9.35 M USD | 3.47 M USD |
| 2025e | 106.42 M USD | 11.26 M USD | 5.42 M USD |
| 2026e | 170.11 M USD | 58.44 M USD | 19.73 M USD |
| 2027e | 222.35 M USD | 97.83 M USD | 30.13 M USD |
| 2028e | 252.17 M USD | 0 USD | 37.5 M USD |
Novan stock margins US66988N1063 · A2AR9U
The Novan margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Novan. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Novan.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Novan's sales revenue. A higher gross margin percentage indicates that the Novan retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Novan's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Novan's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Novan's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Novan. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Novan's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Novan Margin History
| Novan Gross margin | Novan Profit margin | Novan EBIT margin | Novan Profit margin |
|---|---|---|---|
| 2028e | 68.84 % | 0 % | 14.87 % |
| 2027e | 68.84 % | 44 % | 13.55 % |
| 2026e | 68.84 % | 34.35 % | 11.6 % |
| 2025e | 68.84 % | 10.58 % | 5.09 % |
| 2024e | 68.84 % | -12.38 % | 4.6 % |
| 2023e | 68.84 % | -167.28 % | -32.35 % |
| 2022 | 68.84 % | -123.51 % | -132.21 % |
| 2021 | 68.84 % | -1,007.47 % | -1,003.79 % |
| 2020 | 68.84 % | -531.81 % | -595.39 % |
| 2019 | 68.84 % | -626.33 % | -625.31 % |
| 2018 | 68.84 % | -476.79 % | -211.52 % |
| 2017 | 68.84 % | -1,691.12 % | -1,735.05 % |
| 2016 | 68.84 % | 0 % | 0 % |
| 2015 | 68.84 % | 0 % | 0 % |
| 2014 | 68.84 % | -10,754.55 % | -10,354.55 % |
| 2013 | 68.84 % | -235.06 % | -228.04 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2013 | 68.84 % | -235.06 % | -228.04 % |
| 2014 | 68.84 % | -10,754.55 % | -10,354.55 % |
| 2015 | 68.84 % | 0 % | 0 % |
| 2016 | 68.84 % | 0 % | 0 % |
| 2017 | 68.84 % | -1,691.12 % | -1,735.05 % |
| 2018 | 68.84 % | -476.79 % | -211.52 % |
| 2019 | 68.84 % | -626.33 % | -625.31 % |
| 2020 | 68.84 % | -531.81 % | -595.39 % |
| 2021 | 68.84 % | -1,007.47 % | -1,003.79 % |
| 2022 | 68.84 % | -123.51 % | -132.21 % |
| 2023e | 68.84 % | -167.28 % | -32.35 % |
| 2024e | 68.84 % | -12.38 % | 4.6 % |
| 2025e | 68.84 % | 10.58 % | 5.09 % |
| 2026e | 68.84 % | 34.35 % | 11.6 % |
| 2027e | 68.84 % | 44 % | 13.55 % |
| 2028e | 68.84 % | 0 % | 14.87 % |
Novan Aktienanalyse
What does Novan do?
Novan Inc is a US biotechnology company specializing in the development of therapy and diagnostic products. The company was founded in 2006 and is headquartered in Morrisville, North Carolina. History: Novan was founded by immunologist and dermatologist John M. Newsome, who serves as the company's scientific director. Newsome established the company with the goal of developing new methods for treating skin diseases such as acne, eczema, and psoriatic arthritis. Newsome and his team began their research at the University of North Carolina, where they modified an innovative drug delivery technique to more effectively exploit the molecular properties of medications. Business model: Novan is a biopharmaceutical company focused on the development of therapy and diagnostic products for dermatological conditions. The company utilizes an innovative approach to optimize drug delivery through targeted administration, offering significant advantages over conventional methods of treating skin diseases. Novan's business model combines research, development, and marketing of therapy and diagnostic products. Industries: The company is divided into three main branches: Novan Therapeutics, Novan Technology, and Nitricil. 1. Novan Therapeutics: This division focuses on developing therapeutic products for dermatological conditions. The company utilizes a novel technology applied through ointments and creams to deliver active ingredients deep into the skin, resulting in improved outcomes. 2. Novan Technology: Novan Technology encompasses the company's research area, where the latest scientific advancements in molecular medicine are explored. This division is instrumental in the development of new compounds and therapies, ensuring Novan remains at the forefront of medical research. 3. Nitricil: Nitricil is an oxygen delivery method developed by Novan, capable of achieving high oxygen concentrations in surrounding tissues. This technology is employed for inflammation treatment and enhancing wound healing. Products: Novan has launched several products, including: 1. SB206: A cream for the treatment of molluscum contagiosum, a viral skin infection primarily occurring in children. 2. SB204: A cream for acne treatment, based on salicylic acid and benzoyl peroxide. 3. SEB-003: An injection in late-stage clinical trials for the treatment of pain associated with knee osteoarthritis. Novan's products can be prescribed by dermatologists and other medical professionals and are available in the United States. Conclusion: Novan Inc is a global leader in the field of molecular medicine and dermatological therapies. The company leads the industry with innovative technologies and products, aiming to improve the lives of patients worldwide. Through the development of new compounds and therapies, Novan contributes to helping individuals with skin problems, ultimately enhancing the lives of millions of people around the world. Novan ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Novan's Sales Figures
The sales figures of Novan originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Novan’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Novan's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Novan’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Novan stock
How much was the turnover of the company Novan compared to the previous year?
The revenue of Novan has increased by 40.99% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Novan?
The revenue of Novan is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Novan measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Novan so important for investors?
The revenue of Novan is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Novan pay?
Over the past 12 months, Novan paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Novan is expected to pay a dividend of 0 USD.
What is the dividend yield of Novan?
The current dividend yield of Novan is .
When does Novan pay dividends?
Novan pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Novan?
Novan paid dividends every year for the past 0 years.
What is the dividend of Novan?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Novan located?
Novan is assigned to the 'Health' sector.
Wann musste ich die Aktien von Novan kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Novan from 1/29/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/29/2025.
When did Novan pay the last dividend?
The last dividend was paid out on 1/29/2025.
What was the dividend of Novan in the year 2024?
In the year 2024, Novan distributed 0 USD as dividends.
In which currency does Novan pay out the dividend?
The dividends of Novan are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Novan
Our stock analysis for Novan Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novan Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
